Indian Journal of Critical Care Medicine

Register      Login



Volume / Issue

Online First

Related articles

VOLUME 23 , ISSUE S2 ( June (Supplement-2), 2019 ) > List of Articles


Drug Interactions of Chronic Neuropsychiatric Drugs in Neuro-critical Care

Shobhana A

Keywords : Adverse drug reactions, Chronic, Neuropsychiatric, Neuro-critical care, Potential drug-drug interaction (pDDIs)

Citation Information : A S. Drug Interactions of Chronic Neuropsychiatric Drugs in Neuro-critical Care. Indian J Crit Care Med 2019; 23 (S2):157-161.

DOI: 10.5005/jp-journals-10071-23195

License: CC BY-NC 4.0

Published Online: 01-06-2019

Copyright Statement:  Copyright © 2019; The Author(s).


Neuro psychiatric illnesses are commonly recognised these days in the intensive care especially with the increasing aging population and more intensive care admissions. However they are still inadequately diagnosed and treated disease entities as a majority of these patients do not seek the help of specialists psychiatrists Of course the number of drugs used in psychiatry has explosively increased in recent years. As a corollary to this, the phenomenon of drug- drug interaction between psychiatric drugs and other drugs has come to the forefront. Drug- drug interaction (DDI)) is the response (pharmacological or clinical) of altered drug effects or increase in adverse effects when two or more drugs are used simultaneously1,2 This effect may be different from the usual action of the individual drugs when used alone. Potential drug- drug interaction (PDDI) are those where theoretically there may be an interaction between the drugs but have not clinically occurred.1,2

PDF Share
  1. Rodrigues AT, Stahlschmidt, Ret al. Prevalence of Potential Drug- Drug Interactions In The Intensive Care Unit of a Brazilian Teaching Hospital. Braz. J. Pharm. Sci. 2017; 53(1) :e16109.
  2. Shakeel F, Aamir M, et al. Epidemiology of Potential Drug-Drug Interactions in Elderly Population Admitted to Critical Care Units of Peshawar, Pakistan. BMC Pharmacology and Toxicology. 2018; 19: 85
  3. Baniasadi S, et al. Important Drug Classes Associated with Potential Drug–Drug Interactions in Critically Ill Patients: Highlights for Cardiothoracic Intensivists. Ann. Intensive Care. 2015; 5:44.
  4. Smithburger PL, Sandra L, et al. Drug–Drug Interactions in the Medical Intensive Care Unit: An Assessment of Frequency, Severity and the Medications involved. International Journal of Pharmacy Practice 2012; 20: 402–408.
  5. Devlin JW, Mallow-Corbett S, Riker RR. Adverse drug events associated with the use of analgesics, sedatives, and antipsychotics in the intensive care unit. Crit Care Med. 2010; 38(6 Suppl):S231-43.
  6. Oðlu GI et al. Potential Drug–Drug Interactions In A Medical Intensive Care Unit Of A University Hospital. Turk J Med Sci.2016; 46: 812–819.
  7. Hamidy YM, Fauzia D. Significant Drug Interactions Among Intensive Care Unit Patients. Asian Journal of Pharmaceutical And Clinical Research.2017 ; Special Issue (May):35–38.
  8. Bhaskaran J, Johnson E, et al. Population Trends In Substances Used In Deliberate Self-Poisoning Leading To Intensive Care Unit Admissions From 2000 To 2010. J Clin Psychiatry.2015;76(12):e1583–9.
  9. Ward M, Schwartz A. Challenges in pharmacologic management of the hospitalized patient with psychiatric comorbidity. Journal of Hospital Medicine 2013;8: 523–529.
  10. American Thoracic Society. Standards For The Diagnosis And Care Of Patients With Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 1995; 152(5):S77–121.
  11. Gacouin A, Maamar A, et al. Patients With Preexisting Psychiatric Disorders Admitted To ICU: A Descriptive And Retrospective Cohort Study. Ann. Intensive Care 2017; (7):1–9.
  12. Wunsch H, Christiansen CF, et al. Psychiatric Diagnoses and Psychoactive Medication Use Among Nonsurgical Critically Ill Patients Receiving Mechanical Ventilation. JAMA. 2014; 311(11):1133–1142.
  13. Shafiekhani M, Mirjalili M, et al. Psychotropic Drug Therapy In Patients In The Intensive Care Unit – Usage, Adverse Effects, And Drug Interactions: A Review. Therapeutics and Clinical Risk Management 2018;14: 1799–1812.
  14. Kutscher EC, Alexander B. A Review of Drug Interactions With Psychiatric Medicines for the Pharmacy Practitioner. Journal of Pharmacy Practice 2007; 20(4):327–333.
  15. Beach SR, Celano CM et al. QTc Prolongation, Torsades de Pointes, and Psychotropic Medications. Psychosomatics 2013; 54:1–13
  16. Strain JJ, Caliendo G et al. Cardiac Drug and Psychotropic Drug Interactions: Significance and Recommendations. Gen Hosp Psychiatry. 1999;21(6):408–429.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.